These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 25023642)

  • 1. EU alerting and reporting systems for potential chemical public health threats and hazards.
    Orford R; Crabbe H; Hague C; Schaper A; Duarte-Davidson R
    Environ Int; 2014 Nov; 72():15-25. PubMed ID: 25023642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances to address European Union Health Security from cross border chemical health threats.
    Duarte-Davidson R; Orford R; Wyke S; Griffiths M; Amlôt R; Chilcott R
    Environ Int; 2014 Nov; 72():3-14. PubMed ID: 24679379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Assessment of Coherence Between Early Warning and Response Systems and Serious Cross-Border Health Threats in the European Union and Turkey.
    Ekmekci PE
    Disaster Med Public Health Prep; 2016 Dec; 10(6):883-892. PubMed ID: 27511433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing and improving cross-border chemical incident preparedness and response across Europe.
    Stewart-Evans J; Hall L; Czerczak S; Manley K; Dobney A; Hoffer S; Pałaszewska-Tkacz A; Jankowska A
    Environ Int; 2014 Nov; 72():30-6. PubMed ID: 24768281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Legal requirements for health protection from the European viewpoint--uniform regulations or reciprocal recognition of public health norms?].
    Schlüter P
    Zentralbl Hyg Umweltmed; 1996 Dec; 199(2-4):105-18. PubMed ID: 9409912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harmonisation of product notification to Poisons Centres in EU Member States.
    Brekelmans P; de Groot R; Desel H; Mostin M; Feychting K; Meulenbelt J
    Clin Toxicol (Phila); 2013 Feb; 51(2):65-9. PubMed ID: 23298219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The early warning and response system for communicable diseases in the EU: an overview from 1999 to 2005.
    Guglielmetti P; Coulombier D; Thinus G; Van Loock F; Schreck S
    Euro Surveill; 2006; 11(12):215-20. PubMed ID: 17370969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Climate changes, environment and infection: facts, scenarios and growing awareness from the public health community within Europe.
    Bezirtzoglou C; Dekas K; Charvalos E
    Anaerobe; 2011 Dec; 17(6):337-40. PubMed ID: 21664978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparedness and management of global public health threats at points of entry in Ireland and the EU in the context of a potential Brexit.
    Boland M; O'Riordan M
    Global Health; 2019 Sep; 15(1):53. PubMed ID: 31481126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European activities in radiation protection in medicine.
    Simeonov G
    Radiat Prot Dosimetry; 2015 Jul; 165(1-4):34-8. PubMed ID: 25870434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a new categorization system for pesticides exposure to support harmonized reporting between EU Member States.
    Settimi L; Orford R; Davanzo F; Hague C; Desel H; Pelclova D; Dragelyte G; Mathieu-Nolf M; Adams R; Duarte-Davidson R
    Environ Int; 2016 May; 91():332-40. PubMed ID: 27016706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions.
    Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European survey on decontamination in mass casualty incidents.
    Domres BD; Rashid A; Grundgeiger J; Gromer S; Kees T; Hecker N; Peter H
    Am J Disaster Med; 2009; 4(3):147-52. PubMed ID: 19739457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recording and reporting adverse reactions in clinical trials. New legal provisions according to the 12th Law Amending the German Drug Law (AMG) and the Ordinance on GCP (GCP-V)].
    Eckhardt K; Cremer-Schaeffer P; König J; Paeschke N
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):173-80. PubMed ID: 15726458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EU rules for surveillance and control of communicable diseases].
    Schreck S; Strauss R; Lücking G; Krause G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Feb; 52(2):149-56. PubMed ID: 19190883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [European Union health strategy: public health for European people].
    Oliva AC
    Rev Esp Salud Publica; 2008; 82(3):273-81. PubMed ID: 18711642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Occupational data cards as a source of information for health prevention purposes].
    Bugajska J
    Med Pr; 2000; 51(6):551-61. PubMed ID: 11288683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AETL methodology as a potential solution to current challenges associated with the development and use of acute exposure levels in Seveso II applications.
    Wood M; Pichard A; Gundert-Remy U; de Rooij C; Tissot SM
    J Hazard Mater; 2006 May; 133(1-3):8-15. PubMed ID: 16343752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.